Missouri Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages Missouri Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center: A Comprehensive Overview The Missouri Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center constitutes a legally binding contract that establishes the rights and obligations of both parties in relation to the licensing of certain collateral materials, intellectual property, and research findings. This agreement serves to protect the intellectual property rights of both Gentling, Inc. and The University of North Texas Health Science Center while allowing for the utilization and commercialization of valuable research and technology. It outlines the terms by which Gentling, Inc. obtains the rights to use, develop, and market intellectual property owned by The University of North Texas Health Science Center and vice versa. Key Keywords: Missouri, Collateral License Agreement, Gentling, Inc., University of North Texas Health Science Center, intellectual property, research findings, rights and obligations, commercialization, technology, utilization. Different Types of Missouri Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center: 1. Research Collaboration Collateral License Agreement: This type of agreement focuses on the sharing and collaborative development of research findings, intellectual property, and technology. It fosters a partnership between Gentling, Inc. and The University of North Texas Health Science Center, allowing for joint research efforts, knowledge exchange, and the eventual commercialization of collaborative discoveries. 2. Exclusive Collateral License Agreement: An exclusive license agreement grants Gentling, Inc. exclusive rights to use and develop the intellectual property owned by The University of North Texas Health Science Center. This type of agreement provides Gentling, Inc. with an exclusive competitive advantage in the market, preventing others from utilizing the licensed collateral materials. 3. Non-Exclusive Collateral License Agreement: This agreement allows Gentling, Inc. to utilize the licensed materials or intellectual property alongside other licensees. The University of North Texas Health Science Center can grant non-exclusive licenses to multiple entities, enabling broader utilization and commercialization while retaining ownership of the collateral materials. 4. Royalty-based Collateral License Agreement: In this type of agreement, Gentling, Inc. agrees to pay royalties or a percentage of the revenue generated from the licensed intellectual property to The University of North Texas Health Science Center. These royalties serve as compensation for the use and exploitation of the licensed materials and support ongoing research and development efforts. 5. Material Transfer Agreement (MTA) Collateral License Agreement: An MTA Collateral License Agreement governs the transfer of physical or biological materials between Gentling, Inc. and The University of North Texas Health Science Center. This agreement ensures that both parties adhere to specific terms and conditions regarding the handling, use, and protection of the materials transferred. By understanding the different types of Missouri Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center, these institutions can establish fruitful partnerships, create valuable synergies, protect their intellectual property, and contribute to advancements in scientific research and commercialization endeavors.

Missouri Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center: A Comprehensive Overview The Missouri Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center constitutes a legally binding contract that establishes the rights and obligations of both parties in relation to the licensing of certain collateral materials, intellectual property, and research findings. This agreement serves to protect the intellectual property rights of both Gentling, Inc. and The University of North Texas Health Science Center while allowing for the utilization and commercialization of valuable research and technology. It outlines the terms by which Gentling, Inc. obtains the rights to use, develop, and market intellectual property owned by The University of North Texas Health Science Center and vice versa. Key Keywords: Missouri, Collateral License Agreement, Gentling, Inc., University of North Texas Health Science Center, intellectual property, research findings, rights and obligations, commercialization, technology, utilization. Different Types of Missouri Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center: 1. Research Collaboration Collateral License Agreement: This type of agreement focuses on the sharing and collaborative development of research findings, intellectual property, and technology. It fosters a partnership between Gentling, Inc. and The University of North Texas Health Science Center, allowing for joint research efforts, knowledge exchange, and the eventual commercialization of collaborative discoveries. 2. Exclusive Collateral License Agreement: An exclusive license agreement grants Gentling, Inc. exclusive rights to use and develop the intellectual property owned by The University of North Texas Health Science Center. This type of agreement provides Gentling, Inc. with an exclusive competitive advantage in the market, preventing others from utilizing the licensed collateral materials. 3. Non-Exclusive Collateral License Agreement: This agreement allows Gentling, Inc. to utilize the licensed materials or intellectual property alongside other licensees. The University of North Texas Health Science Center can grant non-exclusive licenses to multiple entities, enabling broader utilization and commercialization while retaining ownership of the collateral materials. 4. Royalty-based Collateral License Agreement: In this type of agreement, Gentling, Inc. agrees to pay royalties or a percentage of the revenue generated from the licensed intellectual property to The University of North Texas Health Science Center. These royalties serve as compensation for the use and exploitation of the licensed materials and support ongoing research and development efforts. 5. Material Transfer Agreement (MTA) Collateral License Agreement: An MTA Collateral License Agreement governs the transfer of physical or biological materials between Gentling, Inc. and The University of North Texas Health Science Center. This agreement ensures that both parties adhere to specific terms and conditions regarding the handling, use, and protection of the materials transferred. By understanding the different types of Missouri Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center, these institutions can establish fruitful partnerships, create valuable synergies, protect their intellectual property, and contribute to advancements in scientific research and commercialization endeavors.